Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy
Biotech
Kyverna begins rolling FDA submission for autoimmune CAR-T in SPS
At the FDA's request, Kyverna will include additional analysis of a natural history study to contextualize miv-cel's benefit, CEO Warner Biddle said.
Angus Liu
May 12, 2026 4:27pm
Oryon shines out of stealth with $21M to fight Parkinson's
Mar 23, 2026 5:00am
Sana shares 14-month data for ‘functional cure’ diabetes program
Mar 13, 2026 10:55am
Gilead inks $8B Arcellx buyout to steer CAR-T into J&J showdown
Feb 23, 2026 7:30am
Quell halts transplant trial to focus on 'chill not kill' Treg
Feb 5, 2026 6:00am
Charles River to close Maryland CDMO site, lay off 20 staffers
Feb 3, 2026 12:20pm
